{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-021241","form_type":"8-K","ticker":"IRIX","cik":"0001006045","company_name":"IRIDEX CORP","filed_at":"2023-05-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.555347+00:00","generated_at":"2026-06-15T03:18:27.140963+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Iridex Q1 2023 revenue $13.7M (+2% YoY), net loss narrows to $2.1M","bullets":["Cyclo G6 revenue $3.7M (+4% YoY); 61 systems sold vs 56 a year ago.","Retina product revenue flat at $7.2M; gross margin fell to 43.3% from 44.6%.","Net loss of $2.1M ($0.13/sh) vs $2.4M ($0.15/sh); cash $11.0M.","FY2023 guidance reaffirmed: revenue $57-59M, Cyclo G6 probes 65k-67k.","FDA clearance received in February for new single-spot 532/577 laser platform."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-021241","json":"https://secwatch.observer/filing/0000950170-23-021241.json","markdown":"https://secwatch.observer/filing/0000950170-23-021241.md","text":"https://secwatch.observer/filing/0000950170-23-021241.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006045/000095017023021241/0000950170-23-021241-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006045/000095017023021241/irix-20230511.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T03:18:27.140963+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4f0a9b3fce1dabe74bc43a9f338f02511fd08fa9","claim":"IRIDEX CORP reported first quarter ended April 1, 2023 results: revenue $13.7 million, net income $2.1 million, EPS $0.13 per share.","evidence_excerpt":"Revenue for the three months ended April 1, 2023 was $13.7 million compared to $13.4 million during the same period of the prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1006045/000095017023021241/0000950170-23-021241-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended April 1, 2023"},{"label":"Revenue","value":"$13.7 million"},{"label":"Net income","value":"$2.1 million"},{"label":"EPS","value":"$0.13 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"6c6dd9b46e0e9c2eb9af7c56ee5d4436b922dad4","claim":"IRIDEX CORP reported full year 2023 results: revenue $57 million to $59 million. Guidance reaffirmed.","evidence_excerpt":"Total revenue for the full year is expected to be $57 million to $59 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1006045/000095017023021241/0000950170-23-021241-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2023"},{"label":"Revenue","value":"$57 million to $59 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}